DEC 14, 2019 6:55 PM PST

Common antibiotic could improve radiation therapy

Have you ever taken the antibiotic vancomycin? As a commonly prescribed antibiotic for colitis and infections caused by Clostridium difficile, vancomycin is not a foreign treatment. But new research suggests it may have even more uses than we previously thought. According to a recent study published in the Journal of Clinical Investigation, taking vancomycin before radiation therapy for cancer could improve the effects of the anti-cancer therapy.

The research was led by senior investigator Andrea Facciabene, Ph.D., who is an associate professor of radiation oncology at the University of Pennsylvania's Perelman School of Medicine in Philadelphia. Conducted on mice, the study shows that the drug changes gram-positive bacteria in the gut, which in turn enhances the immune system so it can fight off tumors more effectively. In other words, since we know that antibiotics alter our gut flora, why not try to manipulate this effect in such a way to create positive conditions for the immune system?

In conducting the study, the researchers gave mice with lung cancer, melanoma, or cervical cancer the antibiotic before exposing them to a type of radiation therapy called hypofractionated radiation (in which an individual is given higher doses of radiation, less frequently). They found that this alteration to the treatment method heightened the antitumor effects of hypofractionated therapy.

"Our study shows that vancomycin seems to boost the effectiveness of the hypofractionated radiation itself on the targeted tumor site while also aiding the abscopal effect, helping the immune system fight tumors away from the treatment site," explains Facciabene.

The abscopal effect refers to the immunological chain reaction that happens as a result of hypofractionated therapy that results in the killing off of distant, nonirradiated tumors as well as localized ones (which is good!).

"Since vancomycin is a widely used clinical agent with a relatively safe profile, these findings raise the potential for utilizing this antibiotic to enhance the effects of [radiation therapy] in [people] with cancer,” concluded Facciabene and her fellow researchers in the study. It is "clear [...] that antibiotics play a role and can potentially impact treatments and outcomes for cancer patients."

Scientists believe administering the common antibiotic vancomycin before radiation therapy could make it more effective against tumors. Photo: Pixabay

"Based on our findings,” continue the authors, “we propose the use of gut modulation in a patient-specific manner in order to translate local antitumor effects of [radiation therapy] into a systemic response that can target metastatic disease.” The next step will be moving their investigations from animal models to human trials.

Sources: Journal of Clinical Investigation, Medical News Today

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
JAN 27, 2020
Cancer
JAN 27, 2020
What can we do about the financial hardships of cancer?
Have you ever had the unfortune of getting out of the hospital and later receiving a medical bill for which you were completely unprepared? Even if you hav...
JAN 27, 2020
Cancer
JAN 27, 2020
How HPV might actually defend against skin cancer
New research from scientists at Massachusetts General Hospital features findings that suggest that immunity to certain strains of HPV (human papillomavirus...
JAN 27, 2020
Drug Discovery & Development
JAN 27, 2020
Immunotherapy Drug Shows Promise for Treating Advanced Prostate Cancer
By the end of the year, an estimated 175,000 men in the United States will have been diagnosed with prostate cancer. Now, researchers from the UK have foun...
JAN 27, 2020
Cancer
JAN 27, 2020
How flavonoids fight against colorectal cancer
New research published in the journal Cancers reports why flavonoids can aid in reducing the risk of colorectal cancer. Flavonoids are compounds found in f...
JAN 27, 2020
Cancer
JAN 27, 2020
Photon up-conversion for new cancer treatments
Scientists from the University of California, Riverside and The University of Texas at Austin have made a breakthrough in materials science that has signif...
JAN 27, 2020
Cancer
JAN 27, 2020
Physical exercise could halve the risk of prostate cancer
New research suggests physical activity could act as a tool to prevent increased risk for prostate cancer. The research comes from scientists at the U...
Loading Comments...